Description
Biopanib 200mg Tablet is a targeted therapy medication used in the treatment of certain types of cancer. Its active ingredient is an anaplastic lymphoma kinase (ALK) inhibitor, which works by blocking the activity of abnormal proteins that promote cancer cell growth. By inhibiting these specific pathways, Biopanib helps to slow down or stop the progression of cancer. It is primarily indicated for patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are ALK-positive. The typical dosage is 200mg twice daily, taken orally with or without food. However, dosage adjustments may be necessary based on individual patient response and tolerance. Common side effects can include visual disturbances, nausea, vomiting, diarrhea, fatigue, and swelling. Less common but serious side effects may occur, so it is crucial to discuss any concerns with a healthcare professional. Biopanib should be stored at room temperature, away from moisture and direct light, and out of reach of children.
